Search Results - "Derakhshani, Afshin"
-
1
Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death
Published in Cancers (23-04-2020)“…Cell death resistance is a key feature of tumor cells. One of the main anticancer therapies is increasing the susceptibility of cells to death. Cancer cells…”
Get full text
Journal Article -
2
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
Published in International journal of molecular sciences (22-06-2020)“…Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) are inhibitory checkpoints that are commonly seen on activated…”
Get full text
Journal Article -
3
Overcoming trastuzumab resistance in HER2‐positive breast cancer using combination therapy
Published in Journal of cellular physiology (01-04-2020)“…Human epidermal growth factor receptor 2 (HER2)‐positive breast cancer (BC) comprises around 20–30% of all BC subtypes and is correlated with poor prognosis…”
Get full text
Journal Article -
4
Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study
Published in Frontiers in genetics (09-06-2020)“…The latest member of the Coronaviridae family, called SARS-CoV-2, causes the Coronavirus Disease 2019 (COVID-19). The disease has caused a pandemic and is…”
Get full text
Journal Article -
5
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
Published in Archives of virology (01-03-2021)“…The number of descriptions of emerging viruses has grown at an unprecedented rate since the beginning of the 21 st century. Severe acute respiratory syndrome…”
Get full text
Journal Article -
6
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
Published in International journal of molecular sciences (05-11-2020)“…Although the ever-increasing number of cancer patients pose substantial challenges worldwide, finding a treatment with the highest response rate and the lowest…”
Get full text
Journal Article -
7
MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers
Published in International journal of molecular sciences (08-04-2020)“…MicroRNAs (miRNAs) are small and non-coding RNAs that display aberrant expression in the tissue and plasma of cancer patients when tested in comparison to…”
Get full text
Journal Article -
8
The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment
Published in International journal of molecular sciences (03-10-2021)“…Gastric cancer (GC), with a heterogeneous nature, is the third leading cause of death worldwide. Over the past few decades, stable reductions in the incidence…”
Get full text
Journal Article -
9
Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review
Published in Frontiers in immunology (14-07-2023)“…For many years, vitamin D has been acknowledged for its role in maintaining calcium and phosphate balance. However, in recent years, research has assessed its…”
Get full text
Journal Article -
10
Deep learning applications in single-cell genomics and transcriptomics data analysis
Published in Biomedicine & pharmacotherapy (01-09-2023)“…Traditional bulk sequencing methods are limited to measuring the average signal in a group of cells, potentially masking heterogeneity, and rare populations…”
Get full text
Journal Article -
11
COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?
Published in Frontiers in oncology (23-04-2020)Get full text
Journal Article -
12
From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy
Published in Molecules (Basel, Switzerland) (14-04-2021)“…Over the past decade, there have been remarkable advances in understanding the signaling pathways involved in cancer development. It is well-established that…”
Get full text
Journal Article -
13
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
Published in Frontiers in immunology (19-05-2021)“…Immune checkpoints (ICs) have pivotal roles in regulating immune responses. The inhibitory ICs in the tumor microenvironment (TME) have been implicated in the…”
Get full text
Journal Article -
14
From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past
Published in Frontiers in immunology (22-02-2021)“…Although melanoma remains the deadliest skin cancer, the current treatment has not resulted in the desired outcomes. Unlike chemotherapy, immunotherapy has…”
Get full text
Journal Article -
15
Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment
Published in Biomedicines (02-04-2021)“…Genetic alterations, especially the K-Ras mutation, carry the heaviest burden in the progression of pancreatic precursor lesions into pancreatic ductal…”
Get full text
Journal Article -
16
Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell Lines
Published in Molecules (Basel, Switzerland) (09-02-2021)“…Glioma is an aggressive type of brain tumor that originated from neuroglia cells, accounts for about 80% of all malignant brain tumors. Glioma aggressiveness…”
Get full text
Journal Article -
17
Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy
Published in Molecules (Basel, Switzerland) (31-05-2022)“…It is estimated that there were 18.1 million cancer cases worldwide in 2018, with about 9 million deaths. Proper diagnosis of cancer is essential for its…”
Get full text
Journal Article -
18
The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy
Published in Biomedicine & pharmacotherapy (01-02-2022)“…Tumor-associated macrophages (TAMs) are among the abundant cell populations of the tumor microenvironment (TME), which have pivotal roles in tumor development,…”
Get full text
Journal Article -
19
Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis
Published in Biomedicine & pharmacotherapy (01-02-2022)“…Ovarian cancer (OC) is one of the worrisome gynecological cancers worldwide. Given its considerable mortality rate, it is necessary to investigate its…”
Get full text
Journal Article -
20
The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers
Published in International journal of molecular sciences (16-07-2020)“…Gynecologic cancers account for approximately 11% of the newly diagnosed cancers in women in the United States and for 18% globally. The presence of…”
Get full text
Journal Article